Company
United StatesPublic company, OTC: AURXNuo Therapeutics, Inc. (OTC: AURX), Houston, TX – FDA Inspections
Inspection records and compliance data for Nuo Therapeutics, Inc. in Houston, Texas. 2 FDA inspections on record, last inspected June 06, 2016. Publicly traded as OTC: AURX.
Company Profile
This profile covers Nuo Therapeutics, Inc. based in Houston, Texas, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected October 9, 2014. Last inspected June 6, 2016.
Most cited issue areas
- DHR - not or inadequately maintained1 inspection
- Evaluation of suppliers, contractors, etc., requirements1 inspection
- Lack of or inadequate procedures1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 6, 2016 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 974135 |
| October 9, 2014 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 900171 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Nuo Therapeutics, Inc.
Stock ticker
AURX
Exchange
OTC
Price as of
November 6, 2026
FEI Number
3004140833
Address
8285 El Rio St Ste 150, Houston, Texas 77054, United States
Country
United States
ID: 5f37dc79-027b-4ac8-bf5a-c210171786c4